Guzhen Cui

5PUBLICATIONS

10CO-AUTHORS

NanoelectronicsCancer therapy (excl. chemotherapy and radiation therapy)Industrial molecular engineering of nucleic acids and proteinsHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Sep 28, 2026

An engineered probiotic Escherichia coli Nissle 1917 strain for Amuc_1100 delivery in a CT26 colorectal tumor model.

|Dec 29, 2025

Synergistic effects of Clostridium butyricum and Akkermansia muciniphila-derived postbiotics ameliorate DSS-induced colitis and associated tumorigenesis through immunomodulation and microbiota regulation in mice.

Dengxiong Hua, Qin Yang, Xuexue Zhou

|Sep 18, 2025

A bacterial PrimPol-reverse transcriptase hybrid protein has a proofreading exonuclease activity that can be transferred to other reverse transcriptases.

Seungjin Kim, Hengyi Xu, Georg Mohr

|Jun 11, 2025

Oral Combined Probiotics Clostridium butyricum and Akkermansia muciniphila Inhibits the Progression of 4T1 Breast Cancer by Activating Bcl-2/Bax Pathway.

Xiaowei Li, Dengxiong Hua, Daoyan Wu

|May 26, 2023

Molecular Basis of TcdR-Dependent Promoter Activity for Toxin Production by Clostridioides difficile Studied by a Heterologous Reporter System.

Xinyue Zhang, Jie Li, Chao Chen

Pageof 1

Frequent Collaborators

Zhenghong Chen

Ya-Jun Liu

Yingang Feng

Seungjin Kim

Hengyi Xu

Georg Mohr

Jun Yao

Y Jessie Zhang

Alan M Lambowitz

Wei Hong

Frequent Collaborators

Zhenghong Chen

Ya-Jun Liu

Yingang Feng

Seungjin Kim